Neuroendocrine neoplasms(NETs)are rare tumors that are increasing in incidence.NETs are characterized by heterogeneous biological behaviour,clinical presentation and course.A sensitive and specific diagnostic and prog...Neuroendocrine neoplasms(NETs)are rare tumors that are increasing in incidence.NETs are characterized by heterogeneous biological behaviour,clinical presentation and course.A sensitive and specific diagnostic and prognostic circulating biomarker useful for all sites,grading and staging of neuroendocrine tumors is still an unmet need.The aim of this article was to review current neuroendocrine and oncologic scientific society guidelines and position statements,and propose recommendations for the most frequent clinical practice queries on circulating neuroendocrine tumors biomarkers.The authors searched for NCCN,NANETS,ESMO,ENETS,UKINETS,AME management guidelines or position statements available from PubMed up to 7th January 2016.From these results we chose guidelines or position statements published by scientific societies or institutions in USA,Europe and Italy with recognized expertise in neuroendocrine tumor patient management.The authors present suggestions for clinical practice based on this analysis.展开更多
文摘Neuroendocrine neoplasms(NETs)are rare tumors that are increasing in incidence.NETs are characterized by heterogeneous biological behaviour,clinical presentation and course.A sensitive and specific diagnostic and prognostic circulating biomarker useful for all sites,grading and staging of neuroendocrine tumors is still an unmet need.The aim of this article was to review current neuroendocrine and oncologic scientific society guidelines and position statements,and propose recommendations for the most frequent clinical practice queries on circulating neuroendocrine tumors biomarkers.The authors searched for NCCN,NANETS,ESMO,ENETS,UKINETS,AME management guidelines or position statements available from PubMed up to 7th January 2016.From these results we chose guidelines or position statements published by scientific societies or institutions in USA,Europe and Italy with recognized expertise in neuroendocrine tumor patient management.The authors present suggestions for clinical practice based on this analysis.
